Evidence map›Paper›PMID 40492079›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Likelihood of blood culture positivity using SeptiCyte RAPID.

Krupa Navalkar, Alyse Wheelock, Melissa Gregory, Danielle Clark, Hannah Kibuuka, Stephen Okello, Sharon Atukunda, Abdullah Wailagala, Peter Waitt, Francis Kakooza and 9 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Krupa NavalkarImmunexpress Inc., Seattle, WA 98109, USA.
Alyse WheelockAustere Environments Consortium for Enhanced Sepsis Outcomes (ACESO), Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA.
Melissa GregoryAustere Environments Consortium for Enhanced Sepsis Outcomes (ACESO), Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA.
Danielle ClarkAustere Environments Consortium for Enhanced Sepsis Outcomes (ACESO), Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA.
Hannah KibuukaMakerere University Walter Reed Program, Kampala, Uganda.
Stephen OkelloMakerere University Walter Reed Program, Kampala, Uganda.
Sharon AtukundaMakerere University Walter Reed Program, Kampala, Uganda.
Abdullah WailagalaMakerere University Infectious Diseases Institute, Kampala, Uganda.
Peter WaittMakerere University Infectious Diseases Institute, Kampala, Uganda.
Francis KakoozaMakerere University Infectious Diseases Institute, Kampala, Uganda.
George OduroKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Nehkonti AdamsInfectious Diseases Directorate, Naval Medical Research Center, Silver Spring, MD, USA.
Maximilian DietrichHeidelberg University, Medical Faculty Heidelberg, Department of Anesthesiology, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany.
Maik von der ForstHeidelberg University, Medical Faculty Heidelberg, Department of Anesthesiology, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany.
Marcus J SchultzDivision of Cardiothoracic and Vascular Anesthesia and Intensive Care Medicine, Department of Anesthesia, General Intensive Care, and Pain Management, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-3969-7792
Neil R AggarwalDivision of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Denver, CO 80045, USA.
Jared A GreenbergRush Medical College and Rush University Medical Center, Chicago, IL 60612, USA.
Thomas D YagerImmunexpress Inc., Seattle, WA 98109, USA.
Richard B BrandonImmunexpress Inc., Seattle, WA 98109, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early diagnosis and identification of causative pathogens using blood culture in patients suspected of Blood Stream Infection (BSI) and sepsis are critical for improving patient outcomes through early and more targeted treatment. Methods: Post-hoc retrospective analysis of indiviudal patient data from three prospective clinical studies, conducted in North America, Europe and Africa, to investigate the association between SeptiCyte RAPID test results (SeptiScores) and blood culture results. Hypothesis: that a significant correlation exists between elevated SeptiScores and positive blood culture results, and between low SeptiScores and negative blood culture results. Results: As the SeptiScore increases, the relative probabilty of a septic patient being BC(+) as opposed to BC(-) also increases. A non-linear positive correlation is observed. Below SeptiScores of 10, the ratio of probabilities of BC(+) sepsis / BC(-) sepsis is <1 while above SeptiScores of 10 this ratio is >1. Thus, septic patients with SeptiScores >10 have a higher probability of being BC(+) compared to BC(-). Conclusions: Elevated SeptiScores, obtained before blood culture results, are indicative of increased blood culture positivity. This may have clinical utility, particularly in resource limited settings, as an aid for improving the efficiency of blood culture practice, for instance by informing patient selection and interpretation of blood culture results.

Indexed as

blood cultureblood stream infectionsepsisSeptiCyte RAPIDSeptiScore

Identifiers

PMID40492079
PMCPMC12148071

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.